Polyrizon (NASDAQ:PLRZ) Shares Down 4.6% – Time to Sell?

Polyrizon Ltd. (NASDAQ:PLRZ)’s share price traded down 4.6% during mid-day trading on Wednesday . The company traded as low as $9.12 and last traded at $9.72. 33,892 shares traded hands during trading, a decline of 42% from the average daily volume of 58,792 shares. The stock had previously closed at $10.19.

Wall Street Analysts Forecast Growth

A number of equities analysts have commented on the stock. Wall Street Zen raised shares of Polyrizon from a “sell” rating to a “hold” rating in a research note on Sunday, June 7th. Weiss Ratings cut shares of Polyrizon from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Wednesday, July 29th. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the stock presently has an average rating of “Sell”.

Polyrizon Stock Performance

The company has a 50-day simple moving average of $12.58 and a 200-day simple moving average of $13.34.

Hedge Funds Weigh In On Polyrizon

A hedge fund recently bought a new stake in Polyrizon stock. Jane Street Group LLC bought a new position in shares of Polyrizon Ltd. (NASDAQ:PLRZ) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 14,032 shares of the company’s stock, valued at approximately $119,000. Jane Street Group LLC owned about 1.35% of Polyrizon at the end of the most recent quarter.

About Polyrizon

Polyrizon Ltd. is a development stage biotech company specializing in the development of medical device hydrogels delivered in the form of nasal sprays. Polyrizon Ltd. is based in Raanana, Israel.